Federal agents investigate the Army's use of Factor VII

05/16/2010 | Sun (Baltimore), The

Agents from the Army's Criminal Investigation Command are investigating the Army's use of a blood-clotting drug, Factor VII, to treat wounded soldiers, sources said. The drug is controversial because some trials have shown it is ineffective, and the FDA and European regulators have warned it can cause fatal blood clots. Novo Nordisk, the maker of the treatment, said it is cooperating with the investigation, while a spokeswoman for the Army Medical Command declined to comment.

View Full Article in:

Sun (Baltimore), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA
Program Manager II
Tufts Health Plan/Network Health
Medford, MA
Director, Medicare Advantage/Medicare Part D Focus
Avalere Health
Washington, DC
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ